News from daiichi sankyo europe gmbh

May 16, 2014, 07:33 ET

Journée Mondiale de l'Hypertension 2014 : Daiichi Sankyo fait du bien à votre cœur !

  - La Journée Mondiale de l'Hypertension a lieu chaque année le 17 mai. Le thème choisi pour 2014 est "Connaître...

May 15, 2014, 09:54 ET

Giornata Mondiale contro l'Ipertensione Arteriosa 2014

Daiichi Sankyo e "Little Hearts" insieme per gli orfani dell'Est Europa  Il 17 maggio ricorre la decima edizione della Giornata Mondiale...

May 15, 2014, 08:50 ET

Daiichi Sankyo pone en marcha la iniciativa "Haz que tu corazón se sienta bien"

Daiichi Sankyo pone en marcha la iniciativa "Haz que tu corazón se sienta bien" -...

Apr 02, 2014, 07:00 ET

Daiichi Sankyo extends the PREFER in AF patient registry to provide additional insights into the long-term management of patients with atrial fibrillation

For European Media Only, Not for UK Media   Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a...

Jun 25, 2013, 04:25 ET

23º Congreso de la Sociedad Europea de Hipertensión - ESH 2013

El estudio SEVITENSION demuestra la superioridad de Sevikar® (olmesartán y amlodipino) frente a la combinación de perindopril...

Jun 25, 2013, 04:25 ET

23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire

De nouvelles données de l'étude SEVITENSION montrent la supériorité de l'association à doses fixes Sevikar®...

Jun 25, 2013, 04:25 ET

Congresso ESH 2013, dallo studio SEVITENSION nuove evidenze sull'efficacia della combinazione fissa olmesartan/amlodipina vs. perindopril/amlodipina nel controllo della pressione arteriosa centrale

Nel corso del 23° Congresso della Società Europea di Ipertensione sono stati presentati gli ultimi dati dello studio SEVITENSION, che...

Feb 06, 2013, 11:29 ET

European patient registry in venous thromboembolism (VTE) - PREFER in VTE - enrols first patient

The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the...

May 15, 2009, 04:00 ET

SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal

- Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the...

Oct 01, 2007, 01:00 ET

DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin

MUNICH, Germany, October 1 /PRNewswire/ -- - New Product Under Development for the Treatment of High Blood Pressure - Approval...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer